Literature DB >> 12531867

Programmed cell death in amyotrophic lateral sclerosis.

Christelle Guégan1, Serge Przedborski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12531867      PMCID： PMC151885          DOI： 10.1172/JCI17610

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  75 in total

1.  Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.

Authors:  M A Mena; U Khan; D M Togasaki; D Sulzer; C J Epstein; S Przedborski
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

Review 2.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase.

Authors:  A G Estévez; J P Crow; J B Sampson; C Reiter; Y Zhuang; G J Richardson; M M Tarpey; L Barbeito; J S Beckman
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene.

Authors:  H Warita; Y Manabe; T Murakami; Y Shiro; I Nagano; K Abe
Journal:  Apoptosis       Date:  2001-10       Impact factor: 4.677

6.  Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  C Kuntz; Y Kinoshita; M F Beal; L A Donehower; R S Morrison
Journal:  Exp Neurol       Date:  2000-09       Impact factor: 5.330

7.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells.

Authors:  C M Troy; M L Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

10.  Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.

Authors:  P H Tu; P Raju; K A Robinson; M E Gurney; J Q Trojanowski; V M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205
View more
  37 in total

Review 1.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

3.  Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.

Authors:  Giuliana Castello Coatti; Miriam Frangini; Marcos C Valadares; Juliana Plat Gomes; Natalia O Lima; Natale Cavaçana; Amanda F Assoni; Mayra V Pelatti; Alexander Birbrair; Antonio Carlos Pedroso de Lima; Julio M Singer; Francisco Marcelo M Rocha; Giovani Loiola Da Silva; Mario Sergio Mantovani; Lucia Inês Macedo-Souza; Merari F R Ferrari; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 4.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

5.  The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model.

Authors:  Haruhisa Inoue; Kayoko Tsukita; Takuji Iwasato; Yasuyuki Suzuki; Masanori Tomioka; Minako Tateno; Masahiro Nagao; Akihiro Kawata; Takaomi C Saido; Masayuki Miura; Hidemi Misawa; Shigeyoshi Itohara; Ryosuke Takahashi
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  Species-dependent neuropathology in transgenic SOD1 pigs.

Authors:  Huaqiang Yang; Guohao Wang; Haitao Sun; Runzhe Shu; Tao Liu; Chuan-En Wang; Zhaoming Liu; Yu Zhao; Bentian Zhao; Zhen Ouyang; Dongshan Yang; Jiao Huang; Yueling Zhou; Shihua Li; Xiaodan Jiang; Zhicheng Xiao; Xiao-Jiang Li; Liangxue Lai
Journal:  Cell Res       Date:  2014-02-28       Impact factor: 25.617

Review 7.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 8.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

9.  Huperzine A provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death.

Authors:  Richelle A Hemendinger; Edward J Armstrong; Rafal Persinski; Julianne Todd; Jean-Luc Mougeot; Franklin Volvovitz; Jeffrey Rosenfeld
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.